Abstract
Background
Methods
Results
Conclusions
Keywords
Introduction
- Lundin N.
- Huttunen T.T.
- Berg H.E.
- Marcano A.
- Felländer-Tsai L.
- Enocson A.
Material and methods
Search strategy
Eligibility criteria
Outcomes of interest
Statistical analysis
Results
Search results

Patient Demographics and Study Characteristics
Study | Number followed (initial THA) | Follow-up (mo) | Years (THA) | Location | Age (y) | Gender (male) | Time post injury (mo) | Control | Oxford level of evidence | Grade rating |
---|---|---|---|---|---|---|---|---|---|---|
Nicol 2021 [ [19] ] | 14 | 60 ± 48 | 2007-2018 | The Ottawa Hospital, Ottawa, Canada | 76 ± 8 | 8 | 22 ± 24 (5-77) | NA | 4 | Low |
Lucchini 2021 [ [20] ] | 68 | 142 ± 19.2 (122–212) | 2000-2008 | Orthopedico Rizzoli, Bologna, Italy | 47.7 ± 11.6 (22-75) | 60 | 143 ± 228 (4–480) | NA | 4 | Low |
Kumar 2021 [ [21] ] | 18 | 28 (12-60) | 2015-2020 | King George's Medical University, Lucknow, India | 44.7 (20-68) | 14 | 30 (3-60). | NA | 4 | Low |
Kassem 2021 [ [22] ] | 45 | 124 (84-180) | NA | Elhadara University Hospital/Elmansoura University Hospital, Egypt | 41.4 (32-61) | 39 | 33 (6-80) | NA | 4 | Very low |
Gracia 2021 [ [23] ] | 39 | 70 (24-132) ORIF 50 Cons 90 | 2004-2014 | Hôspital Pierre-Paul Riquet, Toulouse, France | 54 (20-85); ORIF 59, Cons 49, Control 70 | 30 | 29 (4-115) | NA | 4 | Low |
Rezaie 2020 [ [13] ] | 72 | 35 (12-146) | 2000-2017 | Rothman Orthopaedic Institute, Philadelphia, USA | 57 (25-89) | 37 | 28 ± 32 (1-141) | Primary THA (n=216) | 3 | Low |
Moon 2020 [ [24] ] | 37 | 79 (24-145) | 2002-2017 | Asan Medical Center, Seoul, South Korea | 56.2 (24-81) | 27 | 58 (4–336) | NA | 4 | Low |
Busch 2020 [ [25] ] | 48 (67) | 54 ± 23 (14–88) | 2007-2012 | BG Trauma Center, Tübingen, Germany | 58.5 ± 12.4 (25–87); ORIF 56.2, Cons 63.1 | NA | 107.3 ± 141.9 (1–504) | NA | 4 | Low |
Garcia Rey 2020 [ [26] ] | 78 | 133 (60-276) ORIF 122 Cons 140 | 1986-2012 | Hospital La Paz, Madrid, Spain | 56.9 (23-84); ORIF 52.9, Cons 59.3 | 48 | 69.4 | NA | 4 | Very low |
Do 2020 [ [27] ] | 25 | 50 (24-222) | 2000-2016 | Pusan National University Hospital, Busan, South Korea | 58 (36-85) | 19 | 70 (7-213) | NA | 4 | Very low |
Dawson 2019 [ [4] ] | 25 | 22 | 2013-2017 | Tallaght University Hospital, Dublin Ireland | 53.8 | 17 | 28 | NA | 4 | Very low |
Taheriazam 2019 [ [28] ] | 49 | 44 (24-60) | 1998-2015 | Erfan and Milad Hospital, Tehran, Iran | (17-68) | 43 | 74 (38-205) | NA | 4 | Very low |
Lee 2019 [ [29] ] | 57 | 94 ± 29 | 2003-2012 | Euliji Medical Centre, Seoul, South Korea | 52 ± 13.6 | 31 | 228 (2-720) | Primary THA (n=57) | 3 | Low |
Wang 2018 [ [30] ] | 33 | 138 ± 36 (96-204) | 1997-2008 | Affiliated Hospital of Jiangnan University, Jiangsu, China | 45.1 ± 9.3 (25–68) | 21 | 58 (4-240) | NA | 4 | Low |
Salama 2017 [ [31] ] | 21 | 26 (24–36) | 2011-2014 | San Luigi Hospital of Orbassano, Turin Italy | 57 (29–75) | 12 | NA | NA | 4 | Very low |
Clarke-Jensson 2017 [ [32] ] | 52 | Median 88 (12-252) | 1995-2004 | Multicentre, 6 Norwegian Hospitals | Median 54 (11-82) | 35 | 48 (1-169) | NA | 4 | Low |
Gavaskar 2017 [ [33] ] | 44 (47) | ORIF 82 ± 117 Cons 85 ± 16 | 2006–2010 | Parvathy Hospital, Chennai, India | 47.9 | 31 | 29.2 | NA | 4 | Very low |
Morison 2016 [ [34] ] | 74 | 120 (24-288) | 1987-2011 | St Michaels Hospital, Toronto, Canada | 51 (25–75) | 50 | 48 (12-288) | Primary THA (n=74) | 3 | Low |
Yuan 2015 [ [35] ] | 28 (30) | 60 (25-120) | 1999-2010 | Mayo Clinic, Rochester, USA | 45 (23-75) | 21 | 107 (4-504) | NA | 4 | Low |
Chiu 2015 [ [36] ] | 56 | 120 (60-180) | 1996-2010 | Taipei Veterans Hospital, Taipei, Taiwan | 54.1 (19-86) | 39 | 27 (6-114) | NA | 4 | Low |
Schnaser 2014 [ [37] ] | 17 | 77 ± 33 | 2000-2011 | Metrohealth Medical Centre, Cleveland, USA | 69 (60–81) | 13 | 35 (9-144) | Primary THA (n=44) | 3 | Very low |
Lizaur Utrilla 2012 [ [38] ] | 24 | 101 (60-180) | 1992-2005 | Hospital General Elda, Alicante, Spain | 56.4 (28-77) | 19 | 36 (5-168) | Primary THA (n=48) | 3 | Low |
Lai 2011 [ [39] ] | 31 | 76 (37–101) | 2000-2003 | West China Hospital, Chengdu, China | 51 (27-74); ORIF 50, Cons 52 | 22 | 67 (9-210) | NA | 4 | Low |
Zhang 2011 [ [40] ] | 51 (55) | 64 (32-123) | 1998-2007 | Jishuitan Hospital, Beijing, China | 46.6 (22-65) | 42 | 79.2 (7-360) | NA | 4 | Very low |
Ranawat 2009 [ [12] ] | 32 | 59 (48-116) | 1995-2003 | Hospital for Special Surgery, New York, USA | 52 (20-87) | 23 | 36 (1-227), | NA | 4 | Low |
Bellabarba 2001 [ [41] ] | 30 | 63 (24-140) | 1984-1995 | Rush-Presbyterian-St Luke’s,, Chicago, USA | 51 (26-86); ORIF 50, Cons 52 | 14 | 37 (8-444) | Primary THA (n=204) | 3 | Very low |
Sarkar 2001 [ [42] ] | 22 (37) | 48 (15-168) | 1982-2000 | University of Ulm, Germany | 44 (20-74) | NA | 37 (4-235) | NA | 4 | Very low |
Huo 1999 [ [43] ] | 21 | 65 (48-104) | 1985-1993 | Keggi Orthopaedic Foundation, Connecticut, USA | 52 (23-78) | 19 | 164 (8-480) | NA | 4 | Low |
Weber 1998 [ [44] ] | 63 (66) | 115 (24–240) | 1970-1993 | Mayo Clinic, Rochester, USA | 52 (19-80) | NA | 108 | NA | 4 | Very low |
Acetabular injury
Study | Number followed (onitial THA) | Fracture management | High mechanism injury | Elemental (Letournel fracture classification) | Associated (Letournal fracture classification) | Other |
---|---|---|---|---|---|---|
Nicol 2021 [ [19] ] | 14 | ORIF | 10 | 2; AC 1, Tr 1 | 12; PC+PW 1, T-Type 2, AC+PH 4, ABC 5 | NA |
Lucchini 2021 [ [20] ] | 68 | ORIF 50, conservative 18 | NA | 57; PW 35, PC 3, Tr 19 | 11; PC+PW 3, T-Type 3, AC+PH 1, ABC 4 | Existing sciatic nerve palsy 13 |
Kumar 2021 [ [21] ] | 18 | ORIF | 18 | 6 | NA | Associated dislocation 18, malunion acetabular 2, AVN femoral head 5. existing sciatic nerve palsy 1 |
Kassem 2021 [ [22] ] | 45 | ORIF 36, conservative 9 | NA | 33; PW 27, PC 6 | 12; PC+PW 6, PW+Tr 3, ABC 3 | AVN femoral head 10 |
Gracia 2021 [ [23] ] | 39 | ORIF 19, conservative 20 | 31, ORIF 13, Cons 18 | 17; PW 10, PC 1, AC 1, Tr 5. ORIF 8; PW 4, AC 1, Tr 3. Cons 9; PW 6, PC 1, Tr 2 | 22; T-Type 4, PW+Tr 3, AC+PH 3, ABC 5. ORIF 11; T-Type 3, AC+PH 3, ABC 5. Cons 11; T-Type 1, PW+Tr 3, AC+PH 2, ABC 5. | Associated dislocation 11, ORIF 4, conservative 7. AVN femoral head 3 |
Rezaie 2020 [ [13] ] | 72 | ORIF | NA | 29; PW 21, PC 3, AC 3, Tr 2 | 41; PC+PW 12, T-Type 1, PW+Tr 11, AC+PH 5, ABC 8 | Associated dislocation 37. acetabular malunion 12. AVN femoral head 40 |
Moon 2020 [ [24] ] | 37 | ORIF | 37 | 18; PW 10, PC 3, AC 2, Tr 3 | 19; PC+PW 3, T-Type 3, PW+Tr 7, AC+PH 1, ABC 5 | Acetabular malunion 4. AVN femoral head 6 |
Busch 2020 [ [25] ] | 48 (67) | ORIF 47, conservative 21 | NA | 29; PW 10, PC 5, AC 5, Tr 9 | 38; PC+PW 2, T-Type 6, PW+Tr 10, AC+PH 3, ABC 17 | Bone loss (AAOS) type I 18, type II 8, type III 15 |
Garcia Rey 2020 [ [26] ] | 78 | ORIF 29, conservative 49 | NA | 27; PW 7, PC 9, AW 2, AC 1, Tr 8. ORIF 6; PW 2, PC 3, AC 1. Cons 21; PW 5, PC 6, AW 2, Tr 8 | 38; PC+PW 12, T-Type 3, PW+Tr 13, ABC 10. ORIF 20; PC+PW 6, T-Type 1, PW+Tr 9, ABC 4. Cons 18; PC+PW 6, T-Type 2, PW+Tr 4, ABC 6 | Bone loss (AAOS) ORIF type I 5, type II 9, type III 10. conservative type I 3, II 14, III 9, IV/V 3. existing sciatic nerve palsy 4 |
Do 2020 [ [27] ] | 25 | ORIF | 17 | 16; PW 13, AC 1, Tr 2 | 9; PC+PW 1, T-Type 1, AC+PH 1, ABC 6 | NA |
Dawson 2019 [ [4] ] | 25 | ORIF | 23 | 9; PW 4, PC 3, AC 2 | 16; PC+PW 3, T-Type 3, PW+Tr 4, ABC 6 | Associated dislocation 6. acetabular malunion 1. previous infection 1 |
Taheriazam 2019 [ [28] ] | 49 | ORIF | NA | NA | NA | Previous infection 2. existing sciatic nerve palsy 4 |
Lee 2019 [ [29] ] | 57 | ORIF 26, conservative 31 | NA | NA | NA | NA |
Wang 2018 [ [30] ] | 33 | ORIF 21, conservative 12 | NA | NA | NA | Acetabular malunion 4 conservative 4. AVN femoral head 10. existing sciatic nerve palsy 2 |
Salama 2017 [ [31] ] | 21 | ORIF 17, conservative 4 | NA | 9 | 12 | AVN femoral head 2. bone loss (Paprovsky) class I 13, class II 6, class III 2 |
Clarke-Jensson 2017 [ [32] ] | 52 | ORIF | NA | 18; PW 12, PC 2, AW 1, AC 2, Tr 1 | 34; PC+PW 2, T-Type 1, PW+Tr 16, AC+PH 9, ABC 6 | NA |
Gavaskar 2017 [ [33] ] | 44 (47) | ORIF 27, conservative 20 | NA | 28; PW 9, PC 5, AW 1, AC 4, Tr 9. ORIF 16; PW 8, PC 2, AC 1, Tr 5. Cons 12; PW 1, PC 3, AW 1, AC 3, Tr 4 | 28; PW 9, PC 5, AW 1, AC 4, Tr 9. ORIF 16; PW 8, PC 2, AC 1, Tr 5. Cons 12; PW 1, PC 3, AW 1, AC 3, Tr 4 | Acetabular malunion 11, ORIF 2, conservative 9 |
Morison 2016 [ [34] ] | 74 | ORIF 58, conservative 16 | NA | 35; PW 23, PC 5, AC 2 , Tr 5 | 39; PC+PW 8, T-Type 8, PW+Tr 7, AC+PH 4, ABC 12 | Existing sciatic nerve palsy 10 |
Yuan 2015 [ [35] ] | 28 (30) | ORIF | NA | 8; PW 6, Tr 2 | 13; PC+PW 3, T-Type 5, PW+Tr 5 | Associated dislocation 6. AVN femoral head 9. previous infection 5. bone loss (AAOS) type I 1, type II 9, type II 1, type IV 1. existing sciatic nerve palsy 7 |
Chiu 2015 [ [36] ] | 56 | ORIF | NA | NA | NA | Acetabular malunion 0. bone loss (Paprovsky) class I 8, class II 7, class III 5 |
Schnaser 2014 [ [37] ] | 17 | ORIF 14, conservative 3 | 8 | 3; PW 2, Tr 1. ORIF 2; PW 2. Conservative 1; Tr 1 | 14; PC+PW 5, T-Type 2, AC+PH 2, ABC 5. ORIF 12; T-Type 2, AC+PH 2, ABC 3. Cons 2; ABC 2 | Associated dislocation 10 |
Lizaur Utrilla 2012 [ [38] ] | 24 | ORIF 9, conservative 15 | 24 | 10; PW 8, AC 2. ORIF 4; PW 2, AC 2. Cons 6; PW 6. | 14; PC+PW 9, T-Type 5. ORIF 5; PC+PW 5. Cons 9; PC+PW 4, T-Type 5 . | Associated dislocation 6, ORIF 3, conservative 3. acetabular malunion 0. bone loss (AAOS) type I 5, type II 6, type III 9. |
Lai 2011 [ [39] ] | 31 | ORIF 19, conservative 12 | 30 | 15, ORIF 8, Cons 7 | 16, ORIF 11, Cons 5 | Bone loss (AAOS) type I 9, type II 3, type III 2. existing sciatic nerve palsy 2 |
Zhang 2011 [ [40] ] | 51 (55) | ORIF 32, conservative 23 | 49 | 33; PW 28, AC 1, Tr 4. ORIF 16; PW 14, Tr 2. Cons 17; PW 14, AC 1, Tr 2 | 22; PC+PW 6, PW+Tr 13, ABC 3. ORIF 16; PC+PW 5, PW+Tr 10, ABC 1. Cons 6; PC+PW 1, PW+Tr 3, ABC 2 | Bone loss (AAOS) type I segmental 20, type II 8, type III 4, type IV 1 |
Ranawat 2009 [ [12] ] | 32 | ORIF 24, conservative 8 including Girdlestone 1 | 22 | 17; PW 13, PC 1, Tr 3. ORIF 11; PW 9, PC 1, Tr 2. Cons 6; PW 4, Tr 2 | 14; PC+PW 5, T-Type 1, PW+Tr 3, AC+PH 1, ABC 4. ORIF 13; PC+PW 5, T-Type 1, PW+Tr ,3 AC+PH 1, ABC 3. Cons 1; ABC 1 | Acetabular malunion 1. previous infection 8. bone loss (AAOS) type I 13, type II 1, type III 2. existing sciatic nerve palsy 8 |
Bellabarba 2001 [ [41] ] | 30 | ORIF 15, conservative 15 | 30 | NA | NA | AVN femoral head 13, ORIF 7, conservative 6 |
Sarkar 2001 [ [42] ] | 22 (37) | ORIF 31, conservative 6 | 33 | 14; PW 3, PC 11 | 17; PC+PW 6, T-Type 2, PW+Tr 2, AC+PH 1, ABC 6 | AVN femoral head 5, previous infection 4 |
Huo 1999 [ [43] ] | 21 | ORIF 7, conservative 14 | 21 | 9; PW 9 | 12; PC+PW 5, T-Type 2, PW+Tr 3, ABC 2 | AVN femoral head 15 |
Weber 1998 [ [44] ] | 63 (66) | ORIF | 57 | 35; PW 27, PC 1, AC 3, Tr 4 | 31; PC+PW 11, T-Type 4, PW+Tr 6, ABC 10 | Associated dislocation 37, acetabular malunion 13, bone loss (AAOS) type I 7, type II 8, type III 5. existing sciatic nerve palsy 13 |
Surgical technique
Study | Initial THA | Acetabular implant (uncemented) | Other | Removal metal | Bone grafting | Surgical approach | Blood loss (mL) | Operative time (min) |
---|---|---|---|---|---|---|---|---|
Nicol 2021 [ [19] ] | 14 | 14 | Revision type implant 2 | NA | NA | Posterior 10, aanterolateral 10, lateral 2. ORIF - Kocher Langenbach 2, Ilioinguinal 8, stoppa 5, dual 2, hip dislocation 1 | NA | 153 ± 59 |
Lucchini 2021 [ [20] ] | 68 | 68 | NA | 8 | NA | Anterolateral 68 | NA | NA |
Kumar 2021 [ [21] ] | 18 | 18 | NA | 15 | NA | Posterior 18 | 530 (350-800) | 120 (90-160) |
Kassem 2021 [ [22] ] | 45 | 28 | 2-stage procedure 6 | 10 | 30 | Posterior 45 | 2025 ORIF 2153 Cons 1514 | 125 (100-180) ORIF 165 Cons 127 |
Gracia 2021 [ [23] ] | 39 | 35 | Dual mobility 18, plate construct 2 | 7 | 14 | Posterior 39 | 560 (300-1000) ORIF 425 Cons 688 | 92 (55-134), ORIF 75, Cons 108. |
Rezaie 2020 [ [13] ] | 72 | NA | Cage 2 | 20 | 14 | Posterior 17, lateral 49, anterior 6. ORIF - Kocher Langenbach 50, ilioinguinal 15, dual 5 | 483 ± 529 Control 216 | 153 ± 82 Control 113 |
Moon 2020 [ [24] ] | 37 | 37 | NA | NA | NA | Posterior 37 | NA | NA |
Busch 2020 [ [25] ] | 67 | 63 | Screw fixation 29, Reinforcement ring 25 | NA | 55 | Lateral 57. ORIF - Kocher Langenbach 25, ilioinguinal 16, dual 5 | NA | NA |
Garcia Rey 2020 [ [26] ] | 78 | 62 | Plate construct 2 | NA | 16 | Posterior 78 | NA | NA |
Do 2020 [ [27] ] | 25 | 25 | Elevated liner 7 | NA | NA | Posterior 25, ORIF - Kocher Langenbach 14, Stoppa 11 | NA | NA |
Dawson 2019 [ [4] ] | 25 | 19 | Screw fixation 19, 2-stage procedure 1 | NA | 9 | Posterior 13, anterolateral 12. ORIF - Kocher Langenbach 19, ilioinguinal 4, dual 2 | 585 | 91 |
Taheriazam 2019 [ [28] ] | 49 | 47 | 2-stage procedure 2 | NA | NA | NA | NA | NA |
Lee 2019 [ [29] ] | 57 | 57 | NA | NA | NA | Posterior 45, anterolateral 4, dual 7, triradiate 1 | 795.6 ± 587.8 Control 632 | 145.3 ± 41.7 Control 123.7 |
Wang 2018 [ [30] ] | 33 | 33 | Plate construct 4 | 4 | 13 | Posterior 45, anterolateral 4, dual 7, triradiate 1 | 1093. ORIF 1289 Cons 750 | 172 ORIF 189 Cons 143 |
Salama 2017 [ [31] ] | 21 | 21 | Plate construct 2 | 3 | 5 | Posterior 21. ORIF - Kocher Langenbach 21 | NA | 96 (55-200) |
Clarke-Jensson 2017 [ [32] ] | 52 | 19 | NA | NA | NA | NA | NA | NA |
Gavaskar 2017 [ [33] ] | 47 | 47 | Screw fixation 47, plate construct 6 | NA | 19 | Posterior 39, anterolateral 8 | 535 ORIF 448 Cons 652 | 98 ORIF 86 Cons 115 |
Morison 2016 [ [34] ] | 74 | 74 | NA | NA | NA | Posterior 74 | NA | NA |
Yuan 2015 [ [35] ] | 30 | 30 | Elevated liner 8, 2-stage procedure 5 | NA | 10 | Posterior 9, anterolateral 21 | 956 | NA |
Chiu 2015 [ [36] ] | 56 | 56 | NA | 38 | 5 | Posterior 35, anterolateral 21 | NA | NA |
Schnaser 2014 [ [37] ] | 17 | 16 | Screw fixation 10, cage 1 | NA | NA | Posterior 12, anterolateral 5. ORIF - Kocher Langenbach 8, ilioinguinal 6 | 668 ± 547 Control 270 | NA |
Lizaur Utrilla 2012 [ [38] ] | 24 | 24 | Screw fixation 24 | 0 | 15 | Anterolateral 24. ORIF - Kocher Langenbach 7, ilioinguinal 2 | NA | 81 ± 8.8 (65-96) Control 72.7 |
Lai 2011 [ [39] ] | 31 | 31 | NA | NA | 14 | Posterior 31 | 648 ORIF 726, Cons 525 | 123 ORIF 138 Cons 98 |
Zhang 2011 [ [40] ] | 55 | 47 | Screw fixation 35, reinforcement ring 5 | 26 | 26 | Posterior 51, lateral 2, dual 2 | NA | NA |
Ranawat 2009 [ [12] ] | 32 | 32 | Screws fixation 17, elevated liner 19 | 14 | 16 | NA | 718 (100-2000) ORIF 721 Cons 711 | NA |
Bellabarba 2001 [ [41] ] | 30 | 30 | Elevated liner 9 | NA | NA | Posterior 13, transtrochanteric 5 | 898 (250-2900) ORIF 1150 Cons 647 Control 413 | 179 (90-300) ORIF 202 Cons 157 Control 122 |
Sarkar 2001 [ [42] ] | 37 | 28 | NA | NA | NA | Posterior 22, anterolateral 14, iliofemoral 1 | NA | 120 (60-225) |
Huo 1999 [ [43] ] | 21 | 21 | NA | NA | 9 | NA | 960 (500-2200) | 97 (60-190) |
Weber 1998 [ [44] ] | 66 | 22 | NA | 40 | 15 | Posterior 11, anterolateral 19, transtrochanteric 36. ORIF Kocher Langenbach 41, dual 5 | NA | 170 (90-315) |
Functional outcomes
Study | Number functional outcome | Follow-up (mo) | Function (preoperative) | Function (postoperative) |
---|---|---|---|---|
Nicol 2021 [ [19] ] | 14 | 60 ± 48 | NA | Oxford 33.6 ± 8.5 (21-47) |
Lucchini 2021 [ [20] ] | 68 | 142 ± 19.2 (122–212) | HHS 37.6 ± 14.1 (15–70.5) | HHS 88.4 ± 11.6 (43.5–96.9) |
Kumar 2021 [ [21] ] | 18 | 28 (12-60) | NA | HHS 89.72 ± 4.24 (82-95) |
Kassem 2021 [ [22] ] | 45 | 124 (84-180) | Oxford 16.0 ± 4.12 (8-24) | Oxford 39.80 ± 3.08 (33-44) |
Gracia 2021 [ [23] ] | 39 | 70 (24-132), ORIF 50 (24-132), Cons 90 (24-120) | NA | HHS 85 (60-95), ORIF 83 (60-90), Cons 86.9 (60-95). Oxford 40 (19-48) ORIF 39 (19-47) Cons 40.95 (19-47) |
Moon 2020 [ [24] ] | 37 | 79 (24-145) | HHS 42.9 (17-70) | HHS 83.5 (29-97) |
Busch 2020 [ [25] ] | 48 | 54 ± 23 (14–88) | NA | HHS 75.7 ± 21.3 (26.9–100) |
Garcia Rey 2020 [ [26] ] | 78 | 133 (60-276), ORIF 122 (60-240), Cons 140 (60-276) | HHS 52.0 ORIF 50.2 ± 6.4 Cons 53.1 ± 4.9 | HHS 90.6 ORIF 89.5 ±10.5 Cons 91.3 ± 11.9 |
Do 2020 [ [27] ] | 25 | 50 (24-222) | HHS 41 (18-47) | HHS 88 (77-100) |
Taheriazam 2019 [ [28] ] | 49 | 44 (24-60) | HHS 47 (31-66) | HHS 89 (79-95) |
Lee 2019 [ [29] ] | 57 | 94 ± 29 Min 5 years | UCLA Score 3.6 ± 1.3 | UCLA 4.9 ± 1.9 |
Wang 2018 [ [30] ] | 33 | 138 ± 36 (96-204) | HHS 44.0 ± 11.9 (27-58) ORIF 45.9 ± 12.1 (27-58) Cons 40.8 ± 11.3 (29–58) | HHS 88.6 ± 5.1 (74-94) ORIF 89.0 ± 5.4 (74-94) Cons 87.9 ± 4.8 (79–94) |
Salama 2017 [ [31] ] | 21 | 26 (24–36) | HHS 38 (0–70) | HHS 92 (75–100) ORIF 99 (75–100) Cons 85 (79–100) |
Clarke-Jensson 2017 [ [32] ] | 39 | Median 88 (12-252) | HHS 53 ± 10 | HHS 82 ± 16, Pelvic Centre 88 ± 13, Non-specialist institution 75 ± 6 |
Gavaskar 2017 [ [33] ] | 44 | ORIF 82 ± 117 Cons 85 ± 16 | Oxford ORIF 16.7 ± 2.8 Cons 9 ± 3.7 | Oxford ORIF 41.9 ± 3.1, Cons 41.5 ± 3.5 |
Yuan 2015 [ [35] ] | 28 | 60 (25-120) | HHS 39 (3-71) | HHS 82 (21-100) |
Schnaser 2014 [ [37] ] | 17 | 77 ± 33 | NA | HHS 70 ± 25 (19-95) |
Lizaur Utrilla 2012 [ [38] ] | 24 | 101 (60-180) | HHS 35.1 ± 7.9 (22-52) | HHS 77 ± 16.5 (45-94) |
Lai 2011 [ [39] ] | 31 | 76 (37–101) | HHS 49 ORIF 50 ± 16 Cons 48±12 | HHS 89 ± 5 ORIF 87 ± 6 Cons 91 ± 3 |
Zhang 2011 [ [40] ] | 51 | 64 (32-123) | HHS 49.5 (22-78) ORIF 49.5 (30-78) Cons 54.3 (22-76) | NA |
Ranawat 2009 [ [12] ] | 32 | 59 (48-116) | HHS 28 (0-56) | HHS 82 (20-100) ORIF 84 Cons 74 |
Bellabarba 2001 [ [41] ] | 30 | 63 (24-140) | HHS 41 (19-55) ORIF 40 (29-55) Cons 41 (19-52) | HHS 82 (20-100) ORIF 84 Cons 74 |
Sarkar 2001 [ [42] ] | 22 | 48 (15-168) | NA | HHS Very Good 10, Good 3, Fair 2, Poor 7 |
Huo 1999 [ [43] ] | 21 | 65 (48-104) | HHS 30 | HHS 90 |
Weber 1998 [ [44] ] | 63 | 115 (24–240) | HHS 49 | NA |
Revision and Complications
Study | Number followed | Follow-up (mo) | Revision | Infection | Infection revision | Dislocation | Dislocation/instability revision | Aseptic loosening revision | Acetabular loosening revision | Femoral loosening revision | Sciatic nerve palsy |
---|---|---|---|---|---|---|---|---|---|---|---|
Nicol 2021 [ [19] ] | 14 | 60 ± 48 | 3 | 1 | 1 | NA | 0 | 1 | 1 | 0 | NA |
Lucchini 2021 [ [20] ] | 68 | 142 ± 19.2 (122–212) | 8 | 0 | 0 | 2 | 0 | 2 | 0 | 2 | NA |
Kumar 2021 [ [21] ] | 18 | 28 (12-60) | 0 | 1 | 0 | NA | 0 | 0 | 0 | 0 | NA |
Kassem 2021 [ [22] ] | 45 | 124 (84-180) | 2 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 1 |
Gracia 2021 [ [23] ] | 39 | 70 (24-132) ORIF 50 Cons 90 | 7 | 4 ORIF 2 Cons 2 | 4 ORIF 2 Cons 2 | 1 ORIF 1 | 0 | 2 ORIF 1 Cons 1 | NA | NA | 1 ORIF 1 |
Rezaie 2020 [ [13] ] | 72 | 35 (12-146) | NA | 5 | NA | NA | NA | NA | NA | NA | 6 |
Moon 2020 [ [24] ] | 37 | 79 (24-145) | 4 | 3 | 2 | 3 | 1 | 1 | 1 | 0 | NA |
Busch 2020 [ [25] ] | 48 | 54 ± 23 (14–88) | 8 | 1 | 1 | NA | 1 | 5 | 4 | 1 | NA |
Garcia Rey 2020 [ [26] ] | 78 | 133 (60-276) ORIF 122 Cons 140 | 6 ORIF 3 Cons 3 | 0 | 0 | 2 ORIF 1 Cons 1 | 0 | 6 ORIF 3 Cons 3 | 5 ORIF 3 Cons 2 | 1 Cons 1 | NA |
Do 2020 [ [27] ] | 25 | 50 (24-222) | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | NA |
Dawson 2019 [ [4] ] | 25 | 22 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taheriazam 2019 [ [28] ] | 49 | 44 (24-60) | NA | 2 | 2 | 0 | 0 | NA | NA | NA | 0 |
Lee 2019 [ [29] ] | 57 | 94 ± 29 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Wang 2018 [ [30] ] | 33 | 138 ± 36 (96-204) | 3 ORIF 2 Cons 1 | 1 ORIF1 | 1 ORIF 1 | 1 ORIF 1 | 0 | 0 | 0 | 0 | 0 |
Salama 2017 [ [31] ] | 21 | 26 (24–36) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NA |
Clarke-Jensson 2017 [ [32] ] | 52 | Median 88 (12-252) | 11 | 3 | 3 | 4 | 4 | 2 | 2 | 0 | NA |
Gavaskar 2017 [ [33] ] | 44 | ORIF 82 ± 117 Cons 85 ± 16 | 3 ORIF 1 Cons 2 | 1 ORIF1 | 1 ORIF1 | 2 ORIF 1 Cons 1 | 1 Cons 1 | 1 Cons 1 | 1 Cons 1 | 0 | 2 Cons 2 |
Morison 2016 [ [34] ] | 74 | 120 (24-288) | 24 ORIF 21 Cons 3 | 5 | 2 | 8 | 7 | NA | 13 ORIF 2 Cons 11 | 1 | 1 |
Yuan 2015 [ [35] ] | 28 | 60 (25-120) | 3 | 3 | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
Chiu 2015 [ [36] ] | 56 | 120 (60-180) | 3 | 3 | 0 | NA | 0 | 3 | 3 | 0 | NA |
Schnaser 2014 [ [37] ] | 17 | 77 ± 33 | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | NA |
Lizaur Utrilla 2012 [ [38] ] | 24 | 101 (60-180) | 4 | 1 | 1 | 1 | 1 | 2 | 2 Cons 2 | 1 Cons 1 | 0 |
Lai 2011 [ [39] ] | 31 | 76 (37–101) | 0 | 0 | 0 | 2 ORIF 1 Cons 1 | 0 | 0 | 0 | 0 | 1 ORIF 1 |
Zhang 2011 [ [40] ] | 51 | 64 (32-123) | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 3 |
Ranawat 2009 [ [12] ] | 32 | 59 (48-116) | 6 | 6 ORIF 4 Cons 2 | 2 | 3 | 1 | 3 | 1 | 2 | NA |
Bellabarba 2001 [ [41] ] | 30 | 63 (24-140) | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | NA |
Sarkar 2001 [ [42] ] | 22 | 48 (15-168) | 10 | 2 | 2 | 2 | 4 | 3 | 1 | 2 | NA |
Huo 1999 [ [43] ] | 21 | 65 (48-104) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Weber 1998 [ [44] ] | 63 | 115 (24–240) | 17 | 0 | 0 | 0 | 1 | 16 | 9 | 10 | 1 |
Summary results
Demographic | ||||
Number of studies: 29 | Initial THA: 1220 THA (followed >12 months): 1174 | Mean follow-up: 86 months | Gender (% male): 70% | Time interval following fracture: 71 months |
Injury | ||||
High mechanism: 88% (353/401, 14 studies) | Associated dislocation, 43% (125/294, 8 studies) | Elementary Letournel and Judet: 48% (477/985), 24 studies), PW 30%, PC 6%, AW 0.4%, AC 3%, Tr 8% | Associated Letournel and Judet: 52% (508/985, 24 studies). PC+PW 12%, T-Type 7%, PW+Tr 11%, AC+PH 5%, ABC 14% | Initial management: ORIF 75% (919/1220), conservative 25% (301/1220) |
Acetabular malunion: 10% (48/455, 10 studies) | Femoral head AVN: 30% (118/385, 11 studies) | Previous infection: 12% (26/218, 6 studies) | Bone loss, AAOS classification: 56% (209/374, 8 studies) type-1 22%, type-2 18%, type-3 15%, type-4/5 1% | Sciatic nerve injury 10% (64/661, 14 studies) |
Technique | ||||
Uncemented implants: acetabulum 88% (1014/1148, 28 studies), femoral 84% (690/824, 20 studies) | Bone grafting: 39% (294/745, 18 studies) removal of metal: 21% (190/919) | THA approach (24 studies): posterior 64% (670/1042), anterolateral 21% (218/1042) | ORIF approach (9 studies): Kocher Langenbach 63% (187/296), ilioinguinal 17% (51/296), other including dual 20% (58/296) | Mean blood loss: 822 ml (14 studies). Operative time 131 minutes (16 studies) |
Functional | ||||
Harris Hip Score preoperative: 45 (14 studies, 516 THA) | Harris Hip Score postoperative: 86 (18 studies 638 THA) | |||
Revision | ||||
Total: 9.7% (102/1053, 27 studies at mean 91 months) Modern (THA 2000-2020): 7.7% (34/444, 13 studies at mean 77 months) | Aseptic loosening revision: 5.4% (51/948, 25 studies at mean 89 months) | Infection revision: 2.3% (25/1102 28 studies at mean 89 months) | Dislocation/instability revision: 2.2% (22/105, 26 studies at mean 88 months) | |
Complications | ||||
Infection: 3.6% (42/1152, 28 studies at mean 86 months). ORIF 5.4% (29/540, 17 studies at mean 76 months) | Dislocation: 4.4% (42/944, 23 studies at mean 92 months). ORIF 4.7% (16/342, 11 studies at mean 82 months) | Intraoperative sciatic nerve injury: 2.5% (17/668, 15 studies) | Heterotopic ossification: 27.8% (195/702, 17 studies) |
Discussion
- Agarwal S.
- Eckhard L.
- Walter W.L.
- et al.
Conclusions
Conflicts of interest
Appendix
Search Terms
#1 Total hip replacement | ‘total hip arthroplasty’ OR ‘total hip replacement’ OR THA OR THR OR “arthroplasty, replacement, hip” [Mesh] |
#2 Post-traumatic arthritis | ‘post traumatic arthritis’ OR ‘post traumatic osteoarthritis’ OR arthritis OR “Arthritis” [Mesh] |
#3 History acetabular fracture | ‘acetabular fracture’ OR ‘acetabulum fracture’ |
#4 Outcome | Revision OR infection OR complication OR dislocation OR loosening OR fracture OR mortality OR revision OR ‘functional outcome’ OR ‘postoperative complication’ OR ‘blood loss’ OR "Postoperative Complications"[Mesh] OR "Joint Dislocations"[Mesh] OR "Periprosthetic Fractures"[Mesh] OR "Reoperation"[Mesh] |
#1 Total hip replacement | “total hip arthroplasty” OR THA OR “total hip replacement” OR THR OR MeSH descriptor: [Arthroplasty, replacement, hip] explode all trees |
#2 Post-traumatic arthritis | “post traumatic arthritis” OR “post traumatic osteoarthritis” OR arthritis OR MeSH descriptor: [Arthritis] explode all trees |
#3 History acetabular fracture | acetabular OR acetabulum OR MeSH descriptor: [Acetabulum] explode all trees |
#4 Outcome | “functional outcome” OR revision OR infection OR complication OR “postoperative complication” OR dislocation OR loosening OR “peri-prosthetic fracture” OR fracture OR mortality OR revision OR “blood loss” OR MeSH descriptor: [Reoperation] explode all trees OR MeSH descriptor: [Mortality] explode all trees OR MeSH descriptor: [Infections] explode all trees OR MeSH descriptor: [Intraoperative Complications] explode all trees OR MeSH descriptor: [Postoperative Complications] explode all trees OR MeSH descriptor: [Hip Dislocation] explode all trees OR MeSH descriptor: [Blood Loss, Surgical] explode all trees |
#1 Total hip replacement | “total hip arthroplasty” OR THA OR “total hip replacement” OR THR OR ′total hip replacement'/exp |
#2 Post-traumatic arthritis | ‘post traumatic arthritis’ OR ‘post traumatic osteoarthritis’ OR ‘arthritis’ OR ‘arthritis’/exp |
#3 History acetabular fracture | ‘acetabul∗ fracture’ OR ‘acetabulum fracture’/exp |
#4 Outcome | ‘functional outcome’ OR revision OR infection OR complication OR ‘postoperative complication’ OR dislocation OR loosening OR ‘peri-prosthetic fracture’ OR fracture OR mortality OR revision OR ‘blood loss’ OR ′revision arthroplasty'/exp OR 'mortality'/exp OR 'infection'/exp OR ′postoperative complication'/exp OR ′perioperative complication'/exp OR ′hip dislocation'/exp |
Appendix A. Supplementary data
- Conflict of Interest Statement for Hughes
- Conflict of Interest Statement for O’Daly
- Conflict of Interest Statement for O’Driscoll
- Conflict of Interest Statement for O’Byrne
- Conflict of Interest Statement for Davey
- Conflict of Interest Statement for Leonard
References
- Displaced acetabular fractures.Clin Orthop Relat Res. 1988; 230: 83-97
- Epidemiology of pelvic and acetabular fractures in France.Orthop Traumatol Surg Res. 2020; 106: 831-839
- Increasing incidence of pelvic and acetabular fractures. A nationwide study of 87,308 fractures over a 16-year period in Sweden.Injury. 2021; https://doi.org/10.1016/j.injury.2021.03.013
- Total hip arthroplasty for the treatment of osteoarthritis secondary to acetabular fractures treated by open reduction and internal fixation.Eur J Orthop Surg Traumatol. 2019; 29: 1049-1054
- Patient-reported outcome measures after surgery for an acetabular fracture.Bone Joint J. 2018; 100-B: 640-645
- Operative treatment of displaced fractures of the acetabulum. A meta-analysis.J Bone Joint Surg Br. 2005; 87: 2-9
- Long-term total hip arthroplasty rates in patients with acetabular and pelvic fractures after surgery: a population-based cohort study.PLoS One. 2020; 15: e0231092
- Risk of total hip arthroplasty after acetabular fracture fixation: the importance of age.J Arthroplasty. 2021; 36: 3194-3199.e1
- Risk of hip arthroplasty after open reduction internal fixation of a fracture of the acetabulum: a matched cohort study.J Orthop Trauma. 2018; 32: 134-140
- Predictors for long-term hip survivorship following acetabular fracture surgery: importance of gap compared with step displacement.J Bone Joint Surg Am. 2018; 100: 922-929
- Articular step-off and risk of post-traumatic osteoarthritis.Evid Today Inj. 2010; 41: 986-995
- Total hip arthroplasty for posttraumatic arthritis after acetabular fracture.J Arthroplasty. 2009; 24: 759-767
- Total hip arthroplasty after prior acetabular fracture: infection is a real concern.J Arthroplasty. 2020; 35: 2619-2623
- Heterotopic ossification rates after acetabular fracture surgery are unchanged without indomethacin prophylaxis.Clin Orthop Relat Res. 2013; 471: 2776-2782
- Total hip arthroplasty for posttraumatic osteoarthritis following acetabular fracture: a systematic review of characteristics, outcomes, and complications.Chin J Traumatol. 2018; 21: 176-181
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.BMJ. 2009; 339: b2700
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.BMJ. 2008; 336: 924-926
- The 2011 Oxford CEBM levels of evidence.2011: 12 ([accessed 02.02.22])
- Outcomes of total hip arthroplasty after acetabular open reduction and internal fixation in the elderly-acute vs delayed total hip arthroplasty.J Arthroplasty. 2021; 36: 605-611
- Cementless ceramic-on-ceramic total hip arthroplasty in post-traumatic osteoarthritis after acetabular fracture: long-term results.Arch Orthop Trauma Surg. 2021; 141: 683-691
- Outcome of total hip arthroplasty in patients with failed open reduction and internal fixation of acetabular fractures.J Clin Orthop Trauma. 2021; 20: 101480
- Total hip replacements following acetabular fractures. 7 to 15 years clinical and radiological results.Acta Orthop Belg. 2021; 87: 419-426
- Outcomes of acute versus delayed total hip arthroplasty following acetabular fracture.Eur J Orthop Surg Traumatol. 2023; 33: 51-60
- Efficacy of total hip arthroplasty after operatively treated acetabular fracture.Arch Orthop Trauma Surg. 2020; 140: 973-979
- Total hip arthroplasty following acetabular fracture: a clinical and radiographic outcome analysis of 67 patients.Arch Orthop Trauma Surg. 2020; 140: 331-341
- Total hip arthroplasty after acetabular fracture: does initial treatment make any difference to the outcome? A 5- to 23-year follow-up with clinical and radiological analysis.Hip Int. 2020; 30: 339-346
- Cementless total hip arthroplasty after failed internal fixation of acetabular fractures: a single center experience of 25 consecutive patients.J Orthop Surg (Hong Kong). 2020; 282309499020910666
- Conversion to total hip arthroplasty in posttraumatic arthritis: short-term clinical outcomes.Orthop Res Rev. 2019; 11: 41-46
- Use of ceramic-on-ceramic bearing in total hip arthroplasty for posttraumatic arthritis of the hip.J Orthop Surg (Hong Kong). 2019; 272309499019836378
- Delayed total hip arthroplasty after failed treatment of acetabular fractures: an 8- to 17-year follow-up study.J Orthop Surg Res. 2018; 13: 208
- Cementless total hip arthroplasty in the treatment after acetabular fractures.Eur J Orthop Surg Traumatol. 2018; 28: 59-64
- Reduced survival for uncemented compared to cemented total hip arthroplasty after operatively treated acetabular fractures.Injury. 2017; 48: 2534-2539
- Delayed total hip arthroplasty for failed acetabular fractures: the influence of initial fracture management on outcome after arthroplasty.J Arthroplasty. 2017; 32: 872-876
- Total hip arthroplasty after acetabular fracture is associated with lower survivorship and more complications.Clin Orthop Relat Res. 2016; 474: 392-398
- Porous metal acetabular components have a low rate of mechanical failure in THA after operatively treated acetabular fracture.Clin Orthop Relat Res. 2015; 473: 536-542
- Cementless acetabular reconstruction for arthropathy in old acetabular fractures.Orthopedics. 2015; 38: e934-e939
- Acetabular fractures converted to total hip arthroplasties in the elderly: how does function compare to primary total hip arthroplasty?.J Orthop Trauma. 2014; 28: 694-699
- Cementless acetabular reconstruction after acetabular fracture: a prospective, matched-cohort study.J Trauma Acute Care Surg. 2012; 73: 232-238
- Midterm results of uncemented acetabular reconstruction for posttraumatic arthritis secondary to acetabular fracture.J Arthroplasty. 2011; 26: 1008-1013
- Total hip arthroplasty for failed treatment of acetabular fractures: a 5-year follow-up study.J Arthroplasty. 2011; 26: 1189-1193
- Cementless acetabular reconstruction after acetabular fracture.J Bone Joint Surg Am. 2001; 83: 868-876
- Long-term outcome of secondary joint replacement after acetabular fracture.Eur J Trauma. 2001; 27: 301-308
- Total hip replacements done without cement after acetabular fractures: a 4- to 8-year follow-up study.J Arthroplasty. 1999; 14: 827-831
- Total hip arthroplasty after operative treatment of an acetabular fracture.J Bone Joint Surg Am. 1998; 80: 1295-1305
- Radiographic evaluation of acetabular fractures: review and update on methodology.J Am Acad Orthop Surg. 2018; 26: 83-93
- Does surgeon volume affect outcomes following primary total hip arthroplasty? A systematic review.J Arthroplasty. 2018; 33: 3329-3342
- High annual surgeon volume reduces the risk of adverse events following primary total hip arthroplasty: a registry-based study of 12,100 cases in Western Sweden.Acta Orthop. 2019; 90: 153-158
- Risk-Based hospital and surgeon-volume categories for total hip arthroplasty.J Bone Joint Surg Am. 2018; 100: 1203-1208
- Cemented total hip arthroplasty following acetabular fracture.Bone Joint J. 2017; 99-B: 1399-1408
- The use of computer navigation in total hip arthroplasty is associated with a reduced rate of revision for dislocation: a study of 6,912 navigated THA procedures from the Australian orthopaedic association national joint replacement registry.J Bone Joint Surg Am. 2021; 103: 1900-1905
- Total hip arthroplasty after fracture of the acetabulum. Long-term results.J Bone Joint Surg Br. 1990; 72: 761-764
- Uncemented acetabular components for arthritis after acetabular fracture.Clin Orthop Relat Res. 2002; : 164-167
- Total hip arthroplasty after operatively treated acetabular fracture: a concise follow-up, at a mean of twenty years, of a previous report.J Bone Joint Surg Am. 2015; 97: 288-291
- The outcome of the uncemented acetabular component in delayed total hip arthroplasty following acetabular fractures.Bone Jt Open. 2021; 2: 1067-1074
Article info
Publication history
Footnotes
Search Strategies and Materials Available Online. Prospero Registration: CRD42022327855 - https://www.crd.york.ac.uk/PROSPERO/.
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Conor O’Driscoll, Martin Davey and Andrew Hughes. The first draft of the manuscript was written by Conor O’Driscoll and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy